Cargando…

Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)

Migraine is one of the most common and debilitating neurological disorders worldwide. External Trigeminal Nerve Stimulation (e-TNS) is a non-pharmacological, non-invasive therapeutic alternative for patients with migraine. The TEAM study was a prospective, multicenter, randomized, double-blind, sham...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuruvilla, Deena E., Mann, Joseph I., Tepper, Stewart J., Starling, Amaal J., Panza, Gregory, Johnson, Michael A. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948251/ https://www.ncbi.nlm.nih.gov/pubmed/35332216 http://dx.doi.org/10.1038/s41598-022-09071-6

Ejemplares similares

External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial
por: Daniel, Oved, et al.
Publicado: (2022)

Immunohistochemical Analysis of the Expression of Adhesion Proteins: TNS1, TNS2 and TNS3 in Correlation with Clinicopathological Parameters in Gastric Cancer
por: Nizioł, Marcin, et al.
Publicado: (2021)

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
por: Blumenfeld, Andrew M., et al.
Publicado: (2023)

Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial
por: Ashina, Messoud, et al.
Publicado: (2023)

Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials
por: Shapiro, Robert E., et al.
Publicado: (2019)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience
por: Chiang, Chia-Chun, et al.
Publicado: (2017)

Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study
por: Lipton, Richard B., et al.
Publicado: (2019)

Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report
por: Arca, Karissa N., et al.
Publicado: (2020)

Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study
por: Silberstein, Stephen D., et al.
Publicado: (2016)

Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial
por: Traboulsee, Anthony L., et al.
Publicado: (2018)

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
por: Ford, Janet H., et al.
Publicado: (2020)

Abnormal TNS3 gene methylation in patients with congenital scoliosis
por: Wu, YuanTao, et al.
Publicado: (2022)

Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
por: Spierings, Egilius LH, et al.
Publicado: (2017)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura
por: Lipton, Richard B, et al.
Publicado: (2021)

Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial
por: Diener, Hans-Christoph, et al.
Publicado: (2019)

Effectiveness and tolerability of repetitive transcranial magnetic stimulation for preventive treatment of episodic migraine: a single-centre, randomised, double-blind, sham-controlled phase 2 trial (Magnet-EM)
por: Mohamad Safiai, Nabil Izzaatie, et al.
Publicado: (2020)

Development of a Sham Protocol to Investigate Transcutaneous Tibial Nerve Stimulation in Randomised, Sham-Controlled, Double-Blind Clinical Trials
por: Stalder, Stephanie A., et al.
Publicado: (2023)

Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
por: Ailani, Jessica, et al.
Publicado: (2022)

Effect of Whey Protein Supplementation on Inflammatory and Antioxidant Markers, and Clinical Prognosis in Acute Ischemic Stroke (TNS Trial): A Randomized, Double Blind, Controlled, Clinical Trial
por: Hashemilar, Mazyar, et al.
Publicado: (2020)

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension
por: Lipton, Richard B, et al.
Publicado: (2020)

Characterization of the TnsD-attTn7 complex that promotes site-specific insertion of Tn7
por: Mitra, Rupak, et al.
Publicado: (2010)

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study
por: Jensen, Rigmor H., et al.
Publicado: (2023)

Effect of adjunctive intermittent theta-burst repetitive transcranial magnetic stimulation as a prophylactic treatment in migraine patients: A double-blind sham-controlled study
por: Sahu, Amiya Krushna, et al.
Publicado: (2019)

Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
por: Lipton, Richard B., et al.
Publicado: (2019)

Better than sham? A double-blind placebo-controlled neurofeedback study in primary insomnia
por: Schabus, Manuel, et al.
Publicado: (2017)

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)
por: Starling, Amaal J, et al.
Publicado: (2018)

Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial
por: Benussi, Alberto, et al.
Publicado: (2020)

Prophylaxis of migraine: general principles and patient acceptance
por: D’Amico, Domenico, et al.
Publicado: (2008)

MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity
por: Zheng, Jun-Yi, et al.
Publicado: (2021)

TNS1: Emerging Insights into Its Domain Function, Biological Roles, and Tumors
por: Wang, Zhihui, et al.
Publicado: (2022)

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
por: Goadsby, Peter J, et al.
Publicado: (2019)

Stimulating somatosensory psychophysics: a double-blind, sham-controlled study of the neurobiological mechanisms of tDCS
por: Hanley, Claire J., et al.
Publicado: (2015)

High fidelity simulation of the endoscopic transsphenoidal approach: Validation of the UpSurgeOn TNS Box
por: Newall, Nicola, et al.
Publicado: (2022)

The discussion on the validity of sham controls and patient blinding in a sham-controlled acupuncture trial
por: Ge, Yuansen
Publicado: (2022)

Strategies of care for acute treatment of migraine
por: Tepper, Stewart J., et al.
Publicado: (2002)

Arachidonic acid metabolism in TNS-induced chronic and immunologic enteritis in rats, and the effect of 5-ASA
por: Zijlstra, F. J., et al.
Publicado: (1993)

Is Skin-Touch Sham Needle Not Placebo? A Double-Blind Crossover Study on Pain Alleviation
por: Takayama, Miho, et al.
Publicado: (2015)

Neuromodulation for Apathy in Alzheimer’s Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study
por: Padala, Prasad R., et al.
Publicado: (2020)

Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial
por: Martelletti, Paolo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m03875icji7217bht21s86cqul